Immediate Impact
67 standout
Citing Papers
2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock
2025 Standout
2024 Update in Heart Failure
2024 Standout
Works of Thomas Rauwolf being referenced
Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction*
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Thomas Rauwolf | 182 | 89 | 87 | 15 | 236 | |
| Loes Sauren | 152 | 120 | 157 | 13 | 286 | |
| Miguel Alvarez Villela | 58 | 119 | 109 | 25 | 174 | |
| Didier Bresson | 88 | 53 | 32 | 13 | 156 | |
| Abbasali Badami | 70 | 142 | 127 | 14 | 206 | |
| Jeroen J. H. Bunge | 70 | 111 | 151 | 16 | 223 | |
| Rajan Krishnamani | 145 | 154 | 131 | 12 | 288 | |
| Leon Montenij | 79 | 100 | 62 | 21 | 190 | |
| Andrew M. Eibl | 140 | 172 | 142 | 22 | 232 | |
| Sunil Pauwaa | 69 | 149 | 151 | 24 | 235 | |
| František Mlejnský | 81 | 145 | 174 | 12 | 235 |
All Works
Loading papers...